Overview
Nutopi is a company that specializes in the research, development, and small-scale manufacturing of in-vitro diagnostic (IVD) medical devices, including ELISA and turbidimetric assays. They provide services such as assay development, analytical performance evaluation, and verification and validation to ensure compliance with international regulations. Their expertise also includes consulting on lateral flow immunoassay reading methods and failure investigation of assays.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 77 days for 2021).
- 2025not filed
- 202411/08/2025
- 202307/06/2024
- 202201/07/2023
- 202130/09/2022
- 202023/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Offer
- In-vitro diagnostic device research
- In-vitro diagnostic device development
- In-vitro diagnostic device manufacturing
- ELISA tests
- Lateral flow tests
- Clinical chemistry testing
Website technology
- Website
- Wix
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Pielakage 45 | 49 | $1,323.61 | 98% |
Others | 1 | $27.01 | 2% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-04-01.
06 1090 1737 0000 0001 4763 6141
34 1140 2004 0000 3112 1247 5937- 51 1140 2004 0000 3412 0608 1535
Debt
No entries in the National Debtors Register (KRZ).
Public aid
8 public aid cases recorded, with a total value of $46,494.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,148$2,148 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,778$2,778 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 7, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $36,925$36,925 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MargomedS.A. | $6,360,594.28 | margomed.com | ||
| Endotradesp. z o.o. | $912,862.33 | endotrade.pl |
FAQ
Last updated: 2026-04-07